China’s Moonshot AI raises $2B at $20B valuation as demand for open-source AI skyrockets

The valuation multiple here is the real signal: $20B on $200M ARR implies a 100x revenue multiple, which is aggressive even by 2025 standards and suggests investors are pricing in a trajectory well beyond current commercial output. What the headline obscures is that Moonshot is simultaneously being pushed to restructure onshore by Beijing, which complicates the capital table for any foreign LP in this round.

The onshore restructuring pressure is not incidental context. We covered in early May how Moonshot and other Chinese labs are unwinding offshore holding companies under regulatory pressure following Beijing's block of foreign acquisitions in the sector (The Decoder, May 1). That structural shift directly affects how this $2B gets deployed and who can actually hold equity. Meanwhile, the US government benchmark story from May 3 framed China as trailing by eight months on capability, yet Moonshot's ARR growth suggests the cost-first competitive track is generating real revenue regardless of where raw model performance sits. These two threads together indicate the race is bifurcating in ways that valuation multiples alone do not capture.

Watch whether any disclosed foreign institutional investors in this round face regulatory friction over the onshore restructuring requirement in the next 90 days. If offshore LPs are forced to exit or restructure positions, it will confirm that Beijing's governance tightening is already constraining the capital formation story behind this headline valuation.